MOLN: Molecular Partners AG - ADR Company Profile & Statistics

About

Molecular Partners AG is a clinical-stage biotech company. It involved in developing a new class of custom-built protein drugs known as DARPin(R) therapeutics. Molecular Partners AG is based in SWITZERLAND.

Info & Links

CEO

Patrick Amstutz

Headquarters

WAGISTRASSE 14,SCHLIEREN
ZURICH, V8 8952, SWITZERLAND

Auditor

KPMG AG

Share holders

Employees

168

Molecular Partners AG - ADR Statistics

Valuation Measures

Market Capitalization²

219.85M

Enterprise Value

145.28M

Enterprise Value/EBITDA(ttm)

-2.11

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

32.22

Price to Book(mrq)

1.24

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-940.07%

Operating Margin(ttm)

-1043.01%

Profit Margin(ttm)

-1411.89%

Return on Equity(ttm)

-39.31%

Return on Invested Capital(ttm)

-39.60%

Return on Assets(ttm)

-35.46%

Income Statement

Revenue(ttm)

6.84M

Revenue Per Share(ttm)

Gross Profit(ttm)

-50.85M

EBITDA(ttm)³

-68.76M

Net Income Available to Common(ttm)

-70.92M

Diluted EPS(ttm)

-2.15

Share Statistics

Beta (5Y Monthly)

1.00

52-Week Change

27.93%

S&P 500 52-Week Change

26.72%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

37.97M

% Held by Insiders

5.93%

% Held by Institutions

26.55%

Balance Sheet

Total Cash(mrq)

165.95M

Total Cash Per Share(mrq)

Total Debt(mrq)

1.40M

Total Debt/Equity(mrq)

0.88%

Current Ratio(mrq)

14.33%

Quick Ratio(mrq)

14.33%

Book Value Per Share(mrq)

4.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.60

Free Cash Flow(ytd)

-53.87M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MOLN

Molecular Partners AG - ADR

Molecular Partners AG - ADR Profile